Live
- Cold wave conditions in five Bengal districts, says MeT office
- Pawan Kalyan to fly to Hyderabad, amid Allu Arjun's arrest
- High Court Declines Allu Arjun’s Plea to Quash FIR, Suggests Filing Bail Petition
- Husband of Stampede Victim Supports Allu Arjun’s Innocence
- Mehidy Hasan denounces bowlers after 3-0 ODI series loss vs WI
- Chiranjeevi Visits Allu Arjun’s Residence Amid Legal Turmoil
- Over 1.1 million Syrians homeless since recent escalation of hostilities: UN
- NBA’s 'commitment to constant innovation' in Covid chaos led to the birth of in-season tournament
- SC issues notice on PIL for conducting public awareness campaign on snake bites
- Varun Dhawan Becomes First from Film Fraternity to Support Allu Arjun
Indian origin scientist at MIT develops Artificial liver, earns Heinz award
Highlights
An Indian-origin scientist at MIT, who has developed artificial human microlivers for drug testing, has won a prestigious $250,000 Heinz award for her work in tissue engineering and disease detection.
An Indian-origin scientist at MIT, who has developed artificial human microlivers for drug testing, has won a prestigious $250,000 Heinz award for her work in tissue engineering and disease detection.
.jpg)
Sangeeta Bhatia at the Massachusetts Institute of Technology has been named the recipient of the 2015 Heinz Award. The Heinz Awards annually recognise individuals for their extraordinary contributions to arts and humanities; environment; human condition; public policy; and technology, the economy, and employment.
The Heinz Awards annually recognise individuals for their extraordinary contributions to arts and humanities; environment; human condition; public policy; and technology, the economy, and employment. “This type of recognition helps to bring science into the public eye so that everyone can appreciate the dedication and innovation that is happening in laboratories all over the country,” said Bhatia.
Bhatia’s team has pioneered the fabrication of artificial human microlivers, which are being used by many biopharmaceutical companies to test the toxicity of drug candidates. She is also using microlivers in the lab to model malaria infection and test drugs that can eradicate malaria parasites completely - even the parasite reservoirs that remain in the liver after a patient’s symptoms subside.
Next Story
ADVERTISEMENT
